3.連結財務諸表及び主な注記

(1)連結貸借対照表

 

 

 

 

 

 

 

 

 

 

 

(単位:百万円)

 

 

 

 

 

 

 

 

 

 

前連結会計年度

(2025年3月31日)

当連結会計年度

(2026年3月31日)

資産の部

 

 

 

流動資産

 

 

 

 

現金及び預金

55,425

50,032

 

 

受取手形

4,137

5,032

 

 

売掛金

58,975

62,535

 

 

電子記録債権

1,529

3,244

 

 

有価証券

4,337

4,463

 

 

商品及び製品

44,917

53,225

 

 

仕掛品

1,397

1,412

 

 

原材料及び貯蔵品

25,227

29,672

 

 

未収入金

6,639

5,751

 

 

その他

4,436

4,897

 

 

貸倒引当金

229

114

 

 

流動資産合計

206,794

220,153

 

固定資産

 

 

 

 

有形固定資産

 

 

 

 

 

建物及び構築物(純額)

48,231

51,976

 

 

 

機械装置及び運搬具(純額)

26,252

30,563

 

 

 

土地

9,507

9,923

 

 

 

建設仮勘定

21,277

23,770

 

 

 

その他(純額)

4,049

4,731

 

 

 

有形固定資産合計

109,317

120,966

 

 

無形固定資産

 

 

 

 

 

のれん

640

499

 

 

 

その他

3,411

3,255

 

 

 

無形固定資産合計

4,051

3,755

 

 

投資その他の資産

 

 

 

 

 

投資有価証券

35,393

30,600

 

 

 

長期貸付金

521

474

 

 

 

長期前払費用

2,576

6,791

 

 

 

退職給付に係る資産

11,032

12,285

 

 

 

繰延税金資産

2,092

1,796

 

 

 

その他

1,977

1,962

 

 

 

貸倒引当金

49

49

 

 

 

投資その他の資産合計

53,544

53,860

 

 

固定資産合計

166,914

178,582

 

資産合計

373,708

398,736

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(単位:百万円)

 

 

 

 

 

 

 

 

 

 

前連結会計年度

(2025年3月31日)

当連結会計年度

(2026年3月31日)

負債の部

 

 

 

流動負債

 

 

 

 

支払手形及び買掛金

19,869

24,225

 

 

短期借入金

7,212

11,013

 

 

未払金

18,797

16,342

 

 

未払費用

6,490

6,611

 

 

未払法人税等

1,492

5,588

 

 

返金負債

412

106

 

 

役員賞与引当金

195

170

 

 

その他

1,136

1,070

 

 

流動負債合計

55,606

65,128

 

固定負債

 

 

 

 

社債

14,000

14,000

 

 

長期借入金

20,884

24,171

 

 

繰延税金負債

10,358

10,500

 

 

役員退職慰労引当金

10

13

 

 

退職給付に係る負債

434

356

 

 

長期預り金

3,311

3,227

 

 

その他

582

1,234

 

 

固定負債合計

49,581

53,503

 

負債合計

105,188

118,631

純資産の部

 

 

 

株主資本

 

 

 

 

資本金

14,932

14,932

 

 

資本剰余金

15,861

15,879

 

 

利益剰余金

202,714

210,323

 

 

自己株式

6,527

16,503

 

 

株主資本合計

226,981

224,632

 

その他の包括利益累計額

 

 

 

 

その他有価証券評価差額金

12,374

11,340

 

 

為替換算調整勘定

23,422

37,847

 

 

退職給付に係る調整累計額

4,749

5,181

 

 

その他の包括利益累計額合計

40,546

54,369

 

非支配株主持分

992

1,102

 

純資産合計

268,520

280,104

負債純資産合計

373,708

398,736

 

E00836 42720 日本化薬株式会社 NIPPON KAYAKU CO.,LTD. 通期第1号参考様式 [日本基準](連結) Japan GAAP true cte cte 2025-04-01 2026-03-31 FY 2026-03-31 2024-04-01 2025-03-31 2025-03-31 1 false false false 42720 2026-05-12 42720 2025-04-01 2026-03-31 42720 2025-04-01 2026-03-31 jppfs_cor:CapitalStockMember 42720 2025-04-01 2026-03-31 jppfs_cor:CapitalSurplusMember 42720 2025-04-01 2026-03-31 jppfs_cor:ForeignCurrencyTranslationAdjustmentMember 42720 2025-04-01 2026-03-31 jppfs_cor:NonControllingInterestsMember 42720 2025-04-01 2026-03-31 jpcrp_cor:ReconcilingItemsMember 42720 2025-04-01 2026-03-31 jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember 42720 2025-04-01 2026-03-31 jpcrp_cor:ReportableSegmentsMember 42720 2025-04-01 2026-03-31 jppfs_cor:RetainedEarningsMember 42720 2025-04-01 2026-03-31 jppfs_cor:ShareholdersEquityMember 42720 2025-04-01 2026-03-31 jpcrp_cor:TotalOfReportableSegmentsAndOthersMember 42720 2025-04-01 2026-03-31 jppfs_cor:TreasuryStockMember 42720 2025-04-01 2026-03-31 tse-acedjpfr-42720:FineChemicalsBusinessUnitReportableSegmentMember 42720 2025-04-01 2026-03-31 tse-acedjpfr-42720:LifeScienceBusinessUnitReportableSegmentMember 42720 2025-04-01 2026-03-31 tse-acedjpfr-42720:MobilityAndImagingBusinessUnitReportableSegmentMember 42720 2025-04-01 2026-03-31 jppfs_cor:ValuationAndTranslationAdjustmentsMember 42720 2025-04-01 2026-03-31 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember 42720 2026-03-31 42720 2026-03-31 jppfs_cor:CapitalStockMember 42720 2026-03-31 jppfs_cor:CapitalSurplusMember 42720 2026-03-31 jppfs_cor:ForeignCurrencyTranslationAdjustmentMember 42720 2026-03-31 jppfs_cor:NonControllingInterestsMember 42720 2026-03-31 jpcrp_cor:ReconcilingItemsMember 42720 2026-03-31 jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember 42720 2026-03-31 jpcrp_cor:ReportableSegmentsMember 42720 2026-03-31 jppfs_cor:RetainedEarningsMember 42720 2026-03-31 jppfs_cor:ShareholdersEquityMember 42720 2026-03-31 jpcrp_cor:TotalOfReportableSegmentsAndOthersMember 42720 2026-03-31 jppfs_cor:TreasuryStockMember 42720 2026-03-31 tse-acedjpfr-42720:FineChemicalsBusinessUnitReportableSegmentMember 42720 2026-03-31 tse-acedjpfr-42720:LifeScienceBusinessUnitReportableSegmentMember 42720 2026-03-31 tse-acedjpfr-42720:MobilityAndImagingBusinessUnitReportableSegmentMember 42720 2026-03-31 jppfs_cor:ValuationAndTranslationAdjustmentsMember 42720 2026-03-31 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember 42720 2024-04-01 2025-03-31 42720 2024-04-01 2025-03-31 jppfs_cor:CapitalStockMember 42720 2024-04-01 2025-03-31 jppfs_cor:CapitalSurplusMember 42720 2024-04-01 2025-03-31 jppfs_cor:ForeignCurrencyTranslationAdjustmentMember 42720 2024-04-01 2025-03-31 jppfs_cor:NonControllingInterestsMember 42720 2024-04-01 2025-03-31 jpcrp_cor:ReconcilingItemsMember 42720 2024-04-01 2025-03-31 jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember 42720 2024-04-01 2025-03-31 jpcrp_cor:ReportableSegmentsMember 42720 2024-04-01 2025-03-31 jppfs_cor:RetainedEarningsMember 42720 2024-04-01 2025-03-31 jppfs_cor:ShareholdersEquityMember 42720 2024-04-01 2025-03-31 jpcrp_cor:TotalOfReportableSegmentsAndOthersMember 42720 2024-04-01 2025-03-31 jppfs_cor:TreasuryStockMember 42720 2024-04-01 2025-03-31 tse-acedjpfr-42720:FineChemicalsBusinessUnitReportableSegmentMember 42720 2024-04-01 2025-03-31 tse-acedjpfr-42720:LifeScienceBusinessUnitReportableSegmentMember 42720 2024-04-01 2025-03-31 tse-acedjpfr-42720:MobilityAndImagingBusinessUnitReportableSegmentMember 42720 2024-04-01 2025-03-31 jppfs_cor:ValuationAndTranslationAdjustmentsMember 42720 2024-04-01 2025-03-31 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember 42720 2025-03-31 42720 2025-03-31 jppfs_cor:CapitalStockMember 42720 2025-03-31 jppfs_cor:CapitalSurplusMember 42720 2025-03-31 jppfs_cor:ForeignCurrencyTranslationAdjustmentMember 42720 2025-03-31 jppfs_cor:NonControllingInterestsMember 42720 2025-03-31 jpcrp_cor:ReconcilingItemsMember 42720 2025-03-31 jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember 42720 2025-03-31 jpcrp_cor:ReportableSegmentsMember 42720 2025-03-31 jppfs_cor:RetainedEarningsMember 42720 2025-03-31 jppfs_cor:ShareholdersEquityMember 42720 2025-03-31 jpcrp_cor:TotalOfReportableSegmentsAndOthersMember 42720 2025-03-31 jppfs_cor:TreasuryStockMember 42720 2025-03-31 tse-acedjpfr-42720:FineChemicalsBusinessUnitReportableSegmentMember 42720 2025-03-31 tse-acedjpfr-42720:LifeScienceBusinessUnitReportableSegmentMember 42720 2025-03-31 tse-acedjpfr-42720:MobilityAndImagingBusinessUnitReportableSegmentMember 42720 2025-03-31 jppfs_cor:ValuationAndTranslationAdjustmentsMember 42720 2025-03-31 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember 42720 2024-03-31 42720 2024-03-31 jppfs_cor:CapitalStockMember 42720 2024-03-31 jppfs_cor:CapitalSurplusMember 42720 2024-03-31 jppfs_cor:ForeignCurrencyTranslationAdjustmentMember 42720 2024-03-31 jppfs_cor:NonControllingInterestsMember 42720 2024-03-31 jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember 42720 2024-03-31 jppfs_cor:RetainedEarningsMember 42720 2024-03-31 jppfs_cor:ShareholdersEquityMember 42720 2024-03-31 jppfs_cor:TreasuryStockMember 42720 2024-03-31 jppfs_cor:ValuationAndTranslationAdjustmentsMember 42720 2024-03-31 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember iso4217:JPY xbrli:pure